-
US Records First Human Bird Flu Death, High Levels Of Respiratory Illnesses: Vaccine Stocks Rally
Tuesday, January 7, 2025 - 12:56pm | 518Read More...The Louisiana Department of Health on Monday reported the first human death in the U.S. related to the H5N1 bird flu virus. The CDC is also reporting high levels of acute respiratory illnesses nationwide. The Details: The Louisiana Department of Health said the patient, who was over the age...
-
EXCLUSIVE: The Benzinga Moneymaker Series, 5 Emerging Stocks For Investors To Watch
Thursday, December 15, 2022 - 5:16pm | 815Read More...Investors are on the hunt for undervalued, underfollowed and emerging stocks to spot opportunities. The rise of social media and retail traders gave way to countless methods to uncover new information. For some, this is overwhelming. Benzinga’s Moneymaker Index uses a combination of...
-
What Is RSV, And Why Is Pfizer Paying Up To $525M For Treatment Candidates?
Thursday, April 7, 2022 - 11:30am | 598Read More...Pharma giant Pfizer, Inc. (NYSE: PFE), which has found huge success with its COVID franchise, is now looking to conquer another frontier. The company announced a deal Thursday to buy privately held biopharma ReViral, which has a portfolio of antiviral therapeutic candidates, for up to $525...
-
Enanta's Respiratory Virus Drug Aces Midstage Study
Friday, June 14, 2019 - 2:06pm | 294Read More...The thinly traded, small-cap biotech Enanta Pharmaceuticals Inc (NASDAQ:ENTA) announced results Friday from a midstage study. What Happened Enanta released top-line results from a Phase 2a study that evaluated EDP-938; it showed a highly statistically significant reduction in viral...





